MTNB
Matinas BioPharma Holdings, Inc.
-0.01 (-3.45%)0.16USD499K成交股數2.3M市值–本益比(近四季)2.1股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | 85K | 2.2M | 3.4M | 3.4M | 3.7M | 3.3M | 3.6M |
| 銷售管理費用 | 1.6M | 1.9M | 1.6M | 1.6M | 1.8M | 1.9M | 2.1M | 2.5M | 2.5M | 2.2M | 2.8M | 2.6M |
| 營業利益 | −1.6M-15% | −1.9M-1% | −1.6M-63% | −1.6M-73% | −1.8M-69% | −1.9M-67% | −4.4M-29% | −5.8M-5% | −5.9M | −5.9M | −6.1M | −6.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −1.3M-75% | −1.9M+16% | −1.9M-55% | −1.5M-73% | −5.2M-10% | −1.7M-69% | −4.3M-29% | −5.7M-6% | −5.8M | −5.3M | −6.1M | −6.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.21-80% | -0.30-9% | -0.24-72% | -0.40-65% | -1.03-23% | -0.33-91% | -0.85-39% | -1.15+3733% | -1.34 | -3.83 | -1.39 | -0.03 |
| 稀釋股數 | 6.4M | 6.4M | 5.5M | 5.4M | 5.1M | 5.1M | 5.0M | 5.0M | 4.3M | 4.3M | 4.3M | 217M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 761K | 2.4M | 4.0M | 5.4M | 6.5M | 6.9M | 10.3M | 4.2M | 1.1M | 4.8M | 6.4M | 9.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 3.4M | 5.9M | 7.2M | 9.7M | 11.4M | 12.0M | 20.6M | 24.4M | 19.6M | 25.1M | 29.8M | 34.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.6M | 2.9M | 2.4M | 3.2M | 3.7M | 5.8M | 4.8M | 5.3M | 5.1M | 5.9M | 6.6M | 6.2M |
| 股東權益 | 1.8M | 3.0M | 4.8M | 6.5M | 7.7M | 6.3M | 15.8M | 19.1M | 14.6M | 19.2M | 23.2M | 27.9M |
| 負債比 | 47.2% | 48.6% | 33.0% | 33.4% | 32.8% | 47.9% | 23.3% | 21.6% | 25.8% | 23.3% | 22.3% | 18.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.6M-20% | – | – | – | −2.0M | – | – | −5.8M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 0 | 0 | 2K | 12K | 18K | 90K | 90K | 94K | 97K | 98K | 97K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −10.3M | –% | -2.00 | – |
| FY2024 | – | – | −24.3M | –% | -4.98 | – |
| FY2023 | 1.1M | -65.6% | −22.9M | -2,093.2% | -5.28 | −15.5M |
| FY2022 | 3.2M | +9560.6% | −21.0M | -658.6% | -0.10 | −20.0M |
| FY2021 | 33K | -79.2% | −23.3M | -70,554.5% | -0.11 | −15.5M |
| FY2020 | 158K | +76.3% | −22.4M | -14,177.0% | -0.12 | −17.4M |
| FY2019 | 90K | -25.0% | −17.4M | -19,343.4% | -0.13 | −14.5M |
| FY2018 | 120K | – | −14.1M | -11,760.4% | -0.15 | −10.9M |